Skip to main content
CSCI logo

COSCIENS Biopharma Inc. (CSCI) Stock Analysis

DELISTED

What happened to COSCIENS Biopharma Inc. (CSCI) stock?

COSCIENS Biopharma Inc. (CSCI) no longer trades on public markets. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
MCap: $8.57M| 52-wk range: $1.75 – $4.61

Market cap $8.57M is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

COSCIENS Biopharma Inc. (CSCI). COSCIENS Biopharma Inc. is a specialty biopharmaceutical company focused on developing and commercializing therapeutics and diagnostic tests across various international markets.

Last analyzed: Jun 15, 2026
COSCIENS Biopharma Inc. is a specialty biopharmaceutical company focused on developing and commercializing therapeutics and diagnostic tests across various international markets. Its lead product, Macrilen, is approved for diagnosing growth hormone deficiency, while a pipeline of preclinical assets targets chronic hypoparathyroidism, amyotrophic lateral sclerosis, and neurological disorders.

COSCIENS Biopharma Inc. (CSCI) Healthcare & Pipeline Overview

Employees40
Model self-rating on this text: 68% (not a measure of the evidence) Updated: Jun 15, 2026

More about this archive record

Can I still buy CSCI shares?

No. CSCI stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for CSCI elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before CSCI stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to COSCIENS Biopharma Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.